Skip to content
Lower risk Medical device recall · FDA · Published March 10, 2023

Howmedica Osteonics recalls Mako Restoris MCK Baseplate Trial (Size 6) with incorrect

Howmedica Osteonics recalls certain Mako Restoris MCK Baseplate Trials (Size 6) due to incorrect laser marking that may affect surgical accuracy. Affected units include specific lot numbers and reference codes.

🇺🇸 FDA recall #Z-1386-2023Medical deviceHowmedica ›
Take action

Contact the company

Recalling firmHowmedica Osteonics Corp.325 Corporate Dr · Mahwah, NJ 07430-2006
✎ GovInfoNow plain-language explainer

Howmedica Osteonics is recalling specific Mako Restoris MCK Baseplate Trials (Size 6) because they have incorrect laser markings. This could lead to surgical errors during partial knee replacements if used without proper verification. Read more at govinfonow.com/recall/58761-howmedica-osteonics-recalls-mako-restoris-mck-baseplate-trial-size-6.

Source Summary by GovInfoNow · govinfonow.com/recall/58761-howmedica-osteonics-recalls-mako-restoris-mck-baseplate-trial-size-6 · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1386-2023

Cite this page

“Howmedica Osteonics recalls Mako Restoris MCK Baseplate Trial (Size 6) with incorrect.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/58761-howmedica-osteonics-recalls-mako-restoris-mck-baseplate-trial-size-6. Based on FDA recall #Z-1386-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1386-2023%22&limit=1).

The FDA announced on March 10, 2023, that Howmedica Osteonics Corp. is recalling stryker MAKO RESTORIS MCK BASEPLATE TRIAL (SIZE 6 RM/LL) units due to incorrect size laser marking. The agency issued the voluntary Class II recall for devices distributed in the U.S., Netherlands, Japan, China, India, Korea, and Australia.

How to tell if you have it

  • stryker MAKO RESTORIS MCK BASEPLATE TRIAL (SIZE 6 RM/LL), REF 170616
  • UPC 00848486003753
  • Lot Number 26250421

The hazard

Certain lots of the Restoris MultiCompartmental Knee (MCK) Tibial Baseplate Trials contain product with incorrect size laser marking. The recall involves 102 units intended for use in a Partial Knee Arthroplasty surgical procedure.

Context

GovInfoNow's records show Howmedica Osteonics Corp. has 46 other recalls on record since July 21, 2017. Recent brand recalls include the OMNIFIT Series I Acetabular Insert Recall (July 30, 2026) and the Triathlon Baseplate Size 4 Recall (May 19, 2026). Other recent recalls of similar products include EMPOWR 3D KNEE Implants Have Incorrect Labeling (Jan. 15, 2026), Think Surgical TMINI Tracking Arrays: Risk of Misalignment Due to Loose Knob (May 8, 2026), and Medline Recalls Knee Surgery Kits Due to Sterility Risk (June 10, 2026).

How to tell if you have this one

Check for the product name 'Mako Restoris MCK Baseplate Trial (Size 6 RM/LL)', reference number '170616', and lot number '26250421'. The product was sold with GTIN 00848486003753.

  • Brand
    Howmedica
  • Product
    stryker MAKO RESTORIS MCK BASEPLATE TRIAL (SIZE 6 RM/LL), REF 170616, intended for use in a Partial Knee Arthroplasty
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    U.S., Netherlands, Japan, China, India, Korea, and Australia.
Recall numberProduct, codes & lotsQuantity
Z-1385-2023stryker MAKO RESTORIS MCK BASEPLATE TRIAL (SIZE 5 RM/LL), REF 170615, intended for use in a Partial Knee Arthroplasty surgical procedure; GTIN 00848486003746, Lot Number 2627042152 units
Z-1386-2023stryker MAKO RESTORIS MCK BASEPLATE TRIAL (SIZE 6 RM/LL), REF 170616, intended for use in a Partial Knee Arthroplasty surgical procedure; GTIN 00848486003753, Lot Number 26250421102 units
Based on the official FDA remedy

What to do — step by step

  1. Verify Product Details

    Check the product's reference number (170616) and lot number (26250421) to confirm if it is affected.

How this recall unfolded

Recall timeline

FDA published this recall 40 days after the firm started it.

1. Firm started the recall: Mar 10, 202312. FDA classified it Class II: Apr 12, 202323. Published in FDA’s Enforcement Report: Apr 19, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1386-2023 (March 10, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1386-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA